Abstract
Hereditary thrombotic thrombocytopenic purpura is an ultra-rare disorder caused by biallelic mutations in the ADAMTS13 gene. Because it can be difficult to diagnose, plasma ADAMTS13 activity assessment should be considered in patients with thrombocytopenia, anemia, and schistocytes on peripheral blood smear. We present the diagnostic evaluation of a patient with hereditary thrombotic thrombocytopenic purpura. Genetic testing revealed one known pathogenic mutation and one novel mutation of ADAMTS13 classified as likely pathogenic on the basis of parental genetic testing and in silico analyses. We further discuss off-label use of prophylactic plasma-derived Factor VIII (Koate-DVI) and the benefit of rare disease registries.
Original language | English (US) |
---|---|
Pages (from-to) | E577-E579 |
Journal | Journal of Pediatric Hematology/Oncology |
Volume | 43 |
Issue number | 4 |
DOIs | |
State | Published - May 2021 |
Keywords
- TTP
- congenital TTP
- hereditary TTP
- thrombotic thrombocytopenic purpura
ASJC Scopus subject areas
- Pediatrics, Perinatology, and Child Health
- Hematology
- Oncology